| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/01/2008 | CN101274953A Method for extracting corosolic acid from plant |
| 10/01/2008 | CN101274932A 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof |
| 10/01/2008 | CN101274921A Synthetic method for taurolidine and pharmaceutical preparations |
| 10/01/2008 | CN101274913A Ornidazole sodium succinate compound, medicinal composition and use thereof |
| 10/01/2008 | CN101274900A 2-hydroxy halogeno-benzyl amino acid compound, preparation therefor and application thereof |
| 10/01/2008 | CN101274118A Physiotherapy electrode plate clamping self-pasting medicine carrying membrane and manufacture method thereof |
| 10/01/2008 | CN101274097A Atomizing grippe vaccine composition and preparation thereof |
| 10/01/2008 | CN101274093A Chinese medicine for curing fungal dermatopathy |
| 10/01/2008 | CN101274091A Compound formulation of capsules for curing cold and preparing technique |
| 10/01/2008 | CN101274080A Compound formulation of tablets for eliminating acne, purging intense heat, defeating viral and bacterial infections |
| 10/01/2008 | CN101274066A Chinese medicine composition for tuberculous |
| 10/01/2008 | CN101274064A Chinese medicinal preparation for hydrophobic |
| 10/01/2008 | CN101274058A Compound formulation of capsules for curing pulmonary tuberculosis with qi-blood deficiency syndrome and preparing technique |
| 10/01/2008 | CN101274050A Application of rhizome of Common Burreed in preparation of medicament for curing virosis |
| 10/01/2008 | CN101274034A Composition for relieving exterior syndrome, clearing heat and detoxicating, method for preparing the same, and quality control method |
| 10/01/2008 | CN101274014A Medicine for curing chronic hepatitis B and posthepatitic cirrhosis |
| 10/01/2008 | CN101273998A Specific herbal medicine prescription for curing severe cold with multiple and complex symptoms |
| 10/01/2008 | CN101273992A Long-acting antibiotic agent for animals and method of preparing the same |
| 10/01/2008 | CN101273991A Applications of tetrahydroindolone/tetrahydroindazolone/tetrahydrocarbazole derivatives and salts thereof in preparation of antiviral medicine |
| 10/01/2008 | CN101273980A Preparation of Enrofloxacin microcapsule and method of preparing the same |
| 10/01/2008 | CN101273977A Preparation technique of tryptanthrin preparations and uses thereof |
| 10/01/2008 | CN101273975A Sustained-release dropping pills of amoxicillin and ambroxol hydrochloride and method of preparing the same |
| 10/01/2008 | CN101273974A Sustained-release dropping pill of azithromycin and method of preparing the same |
| 10/01/2008 | CN101273971A Ethosomes preparation of antimycotics pharmaceutical and method for preparing the same |
| 10/01/2008 | CN100422343C Method of distinguishing drug-resistance of hepatitis b virus |
| 10/01/2008 | CN100422322C Foot and mouth disease virus vaccine |
| 10/01/2008 | CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 10/01/2008 | CN100422307C Antibiotic active matter derived from notoginseng transformed by microbe and its uses |
| 10/01/2008 | CN100422210C Recombinant protective protein from streptococcus pneumoniae |
| 10/01/2008 | CN100422201C Arylation method for the functionalization of O-allyl erythromycin derivatives |
| 10/01/2008 | CN100422184C Preparation method of meluopeinan |
| 10/01/2008 | CN100422182C Imidazopyridine-derivatives as inducible NO-synthase inhibitors |
| 10/01/2008 | CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 10/01/2008 | CN100421732C Plaster for the treatment of dysfunctions and disorders of nails |
| 10/01/2008 | CN100421729C Effervescence tablet of human antalzyme, its preparation and usage |
| 10/01/2008 | CN100421727C Methods |
| 10/01/2008 | CN100421698C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421697C Synergistic medicinal composition containing diammonium glycyrrhizinate and Chinese medicine |
| 10/01/2008 | CN100421692C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| 10/01/2008 | CN100421691C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421688C Synergistic medicinal composition containing thiopronin and Chinese medicine extract |
| 10/01/2008 | CN100421686C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421685C Chinese material medica preparation in use for treating infection of influenza virus, and preparation method |
| 10/01/2008 | CN100421679C Methods and compositions for control of coccidiosis |
| 10/01/2008 | CN100421673C Pharmaceutical use of glycoconjugates CHB for preventing and treating avian flu |
| 10/01/2008 | CN100421670C Amikacin paste and preparing method and use |
| 10/01/2008 | CN100421669C A low-sugar granule for treating infants cold and preparation method thereof |
| 10/01/2008 | CN100421668C Medicine formulation for left-eyed flounder and right-eyed flounder to prevent and control a scites |
| 09/30/2008 | USRE40525 Hepatitis C inhibitor tri-peptides |
| 09/30/2008 | US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS |
| 09/30/2008 | US7429660 Induce immunology response; anticancer agents |
| 09/30/2008 | US7429643 POSH nucleic acids, polypeptides and related methods |
| 09/30/2008 | US7429572 Modified fluorinated nucleoside analogues |
| 09/30/2008 | US7429474 2-O sulfatase compositions and methods of analyzing therewith |
| 09/30/2008 | US7429389 inactivated or attenuated Mycoplasma bovis biotype and a carrier; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections |
| 09/30/2008 | US7429385 Isolated, genetic engineered polypeptide |
| 09/30/2008 | CA2488300C Combination of voriconazole and an antifungal cyp2c19 inhibitor |
| 09/30/2008 | CA2450772C Composition for epigallocatechin gallate |
| 09/30/2008 | CA2377762C Sulfonamidomethyl phosphonate inhibitors of .beta.-lactamase |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/30/2008 | CA2261987C Vectors for inhibiting hiv and tumor growth |
| 09/30/2008 | CA2259140C Method of activating dendritic cells |
| 09/25/2008 | WO2008116194A2 Blockers of pore-forming virulence factors and their use as anti-infectives |
| 09/25/2008 | WO2008115951A1 Fluoroquinolones for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria |
| 09/25/2008 | WO2008115919A2 Methods for the preparation, formulation and use of lithium valproate |
| 09/25/2008 | WO2008115385A2 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | WO2008115281A2 Compounds for treating viral infections |
| 09/25/2008 | WO2008115118A1 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria |
| 09/25/2008 | WO2008114889A1 Oral vaccine |
| 09/25/2008 | WO2008114861A1 Alcohol-containing quinolone pharmaceutical composition |
| 09/25/2008 | WO2008114831A1 Antibacterial agent having sulfonamide group |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114807A1 Weekly administration of dipeptidyl peptidase inhibitors |
| 09/25/2008 | WO2008114787A1 Antiviral agent |
| 09/25/2008 | WO2008114577A2 Antibacterial peptide |
| 09/25/2008 | WO2008114143A1 Extended release formulations of macrolide antibiotic |
| 09/25/2008 | WO2008114037A1 Treatment of inflammation and/or endotoxic shock |
| 09/25/2008 | WO2008113981A1 Antibacterial formulations |
| 09/25/2008 | WO2008113833A1 Novel human anti-r7v antibodies and uses thereof |
| 09/25/2008 | WO2008113606A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | WO2008113558A1 Amino-naphthyridine derivatives |
| 09/25/2008 | WO2008113161A1 Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same |
| 09/25/2008 | WO2008113089A1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| 09/25/2008 | WO2008086971A3 β-LACTAM-CONTAINING FORMULATIONS HAVING INCREASED STABILITY IN AQUEOUS SOLUTION |
| 09/25/2008 | WO2008048348A3 Broad spectrum antiviral compositions |
| 09/25/2008 | WO2008008854A3 Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders |
| 09/25/2008 | WO2008000454A8 Composition for the treatment of skin comprising ink sack liquid of cephalopods |
| 09/25/2008 | WO2007026124A3 Transdermal delivery means of a diuretic agent and/or cardiac glycoside agent |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234388 1,5-Dithiaocta-2,7-diene-5-oxide-1-yl (DODOyl) compounds and derivatives; treating, preventing, or inhibiting transmission of a viral infection |
| 09/25/2008 | US20080234382 Methods for the preparation, formulation and use of lithium valproate |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234343 For oral administration, a transparent liquid mixture of an oily base, a surfactant, polar solvent, and an amount of a drug that is not very soluble in the solvent that exceeds its solubility in the solvent; dugs include 1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide derivatives |
| 09/25/2008 | US20080234333 Containing an acylated aminopiperidin-1-ylcarbonyl group, e.g., N1-1-(4-Benzoylamino-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-2-butyl-N4-hydroxy-succinamide; for treating bacterial diseases |